Abatacept now approved for rheumatoid arthritis after failure of conventional DMARDs

24 April 2013

Following a review, NICE have overturned their previous negative decision for abatacept (Orencia) following the introduction of a patient access scheme.

This new guidance brings the drug in line with other anti-TNF drugs licensed for the treatment of rheumatoid arthritis (pictured) that have been approved by NICE for NHS use | SCIENCE PHOTO LIBRARY
This new guidance brings the drug in line with other anti-TNF drugs licensed for the treatment of rheumatoid arthritis (pictured) that have been approved by NICE for NHS use | SCIENCE PHOTO LIBRARY

Previously, abatacept was only approved for use in rheumatoid arthritis after the failure of a TNF inhibitor. Now it may also be used in adults whose disease has responded inadequately to 2 conventional disease-modifying anti-rheumatic drugs (DMARDs), including methotrexate, provided the manufacturer supplies abatacept with the discount agreed in the patient access scheme.

View Orencia drug record

NICE guidance on abatacept in rheumatoid arthritis after failure of conventional DMARDS

Follow MIMS on Twitter

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

The most up-to-date drug information at your fingertips.

  • Get the prescribing support you need.
  • Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Register Now
Already Registered?

Forgotten password?

More from MIMS

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

New products - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest products added...

A photo of the white and pink Luforbec inhaler.

First metered-dose inhaler certified 'carbon-neutral'

Luforbec (beclometasone/formoterol) has been certified...

Male clinician in white coat showing female patient how to use IQoro device.

Training device for reflux and dysphagia available on NHS

A neuromuscular training device for patients with reflux-based...